m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00509)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
PACERR
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | PTGS2 antisense RNA 1 (PACERR) which bound to IGF2BP2 acts as an m6A-dependent manner to enhance the stability of KLF12 and c-myc in cytoplasm. This study found that LncRNA-PACERR functions as key regulator of TAMs in PDAC microenvironment and revealed the novel mechanisms in cytoplasm and in nucleus. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Pancreatic ductal adenocarcinoma | ICD-11: 2C10.0 | ||
Pathway Response | mRNA surveillance pathway | hsa03015 | ||
RNA degradation | hsa03018 | |||
Cell Process | RNA stability | |||
In-vitro Model | THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 |
PATU-8988 (Human pancreatic adenocarcinoma cell) | ||||
PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
37 (Pancreatic cancer cell) | ||||
In-vivo Model | BALB/c nude mice which were co-injected with THP-1 cells and PATU-8988 cells subcutaneously. | |||
Pancreatic cancer [ICD-11: 2C10]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | PTGS2 antisense RNA 1 (PACERR) which bound to IGF2BP2 acts as an m6A-dependent manner to enhance the stability of KLF12 and c-myc in cytoplasm. This study found that LncRNA-PACERR functions as key regulator of TAMs in PDAC microenvironment and revealed the novel mechanisms in cytoplasm and in nucleus. | |||
Responsed Disease | Pancreatic ductal adenocarcinoma [ICD-11: 2C10.0] | |||
Target Regulator | Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) | READER | ||
Target Regulation | Up regulation | |||
Pathway Response | mRNA surveillance pathway | hsa03015 | ||
RNA degradation | hsa03018 | |||
Cell Process | RNA stability | |||
In-vitro Model | THP-1 | Childhood acute monocytic leukemia | Homo sapiens | CVCL_0006 |
PATU-8988 (Human pancreatic adenocarcinoma cell) | ||||
PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
37 (Pancreatic cancer cell) | ||||
In-vivo Model | BALB/c nude mice which were co-injected with THP-1 cells and PATU-8988 cells subcutaneously. | |||